Mercedes Salgado Fernández

6PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCultural studies of nation and regionCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 18, 2025
Tinzaparin for the prevention of thromboembolic events in ambulatory patients with metastatic colorectal cancer receiving first line treatment: a randomised, clinical trial design.

Mercedes Salgado, Juan de la Camara-Gómez, Ignacio García-Escobar

|Dec 14, 2024
Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO study.

Javier Trujillo-Santos, Ignacio García-Escobar, Mercedes Salgado

|Aug 07, 2024
SEOM clinical guidelines on venous thromboembolism (VTE) and cancer (2023).

Laura Ortega Morán, Francisco José Pelegrín Mateo, Rut Porta Balanyà

|May 11, 2022
Venous Thromboembolism In Cancer Patients: "From Evidence to Care".

Mercedes Salgado, Elena Brozos-Vázquez, Begoña Campos

|Apr 12, 2022
Establishing an Expert Consensus on Key Indicators of the Quality of Life among Breast Cancer Survivors: A Modified Delphi Study.

Izidor Mlakar, Simon Lin, Jama Nateqi

|Jul 02, 2021
Do Clinical Trials Meet Current Care Needs? Views of Digestive Oncology Specialists in Galicia (Spain) Using the Delphi Method.

Ana Fernández Montes, Nieves Martinez-Lago, Juan de la Cámara Gomez

Pageof 1

Frequent Collaborators

2 joint publications

Francisco José Pelegrín-Mateo

2 joint publications

Paula González-Villarroel

2 joint publications

Ignacio García-Escobar

2 joint publications

Eva Martínez-de-Castro